Revenue Acceleration & GTM Strategy

The right partner isn’t found by chance - it’s diagnosed.
Our approach combines a network-agnostic pipeline with a rigorous diagnostic process to ensure every match creates measurable value, not just another introduction.

A broad yet focused ecosystem.
Our European network spans top-tier Pharma decision-makers, a growing number of VCs, and innovative consulting & interim management networks such as the Healthcare Shapers, alongside a growing portfolio of start-ups and scale-ups tackling real problems - from real-time engagement and DTx/SaMD to GenAI content and clinical trial optimization.
Our access is valuable, but it’s never the filter.

Fit comes first.
However, the 'fit' is not defined by our network; it is defined by your need. We begin by diagnosing the core challenge - unclear strategy, missing impact logic, capability gaps (e.g., AI/ML expertise), or inefficient processes.
From there, we apply a proprietary topic and question library built from years of cross-sector work to pinpoint who and what will make a difference for you and your customers.

From Consensus to Consequence
The value is in moving from internal validation to external, accountable challenge. Internally moderated CABs often drift toward groupthink - safe conversations, familiar opinions, and little accountability when flaws surface.

Impact-First moderation changes that.
It brings independence, and consequence into the room, shifting CABs from polite agreement to tangible outcomes.

1. Executive Challenge: As an external moderator, we ensure relevant and appropriate challenge. We nourish new thinking and introduce fresh perspectives on critical topics: industry trends beyond pharma, emerging technologies, regulatory shifts, and new models for assessing value, PMF, and Go-to-Market.

2. Expert Curation: Based on your specific challenge, we help you identify and curate a board of experts beyond ourselves. This often involves sourcing leaders from different industries (e.g., VC/PE, MedTech, DeepTech) and with responsibilities pharma is not used to, such as Chief Product Officers, Chief Revenue Officers, or Customer Success Engineers.

From talk to traction.
Our boards don’t just debate “best practices.” We focus on how to apply them for measurable value - accelerating product innovation, rethinking Go-to-Market, and closing execution gaps across strategy, tech, process, and roles.
All anchored in real-world examples that have already generated revenue.

In short: we turn advisory into advantage, replacing validation with velocity.

Rethinking Product-Market-Fit in Healthcare
In healthcare, Product-Market-Fit is a balancing act between compliance, innovation, and human impact.
Unlike in tech, where PMF means fast iteration and user traction, Pharma often overfits to internal and regulatory needs. The result is Product-Pharma-Fit (PPF) - compliant, perfectly documented, yet detached from real user value.

Impact-First PMF. Where safety meets innovation.
We help clients avoid this trap by ensuring compliance without compromise. Our Impact-First PMF - secures safety and compliance (GDPR, EU AI Act etc.) without extinguishing innovation or losing user relevance.

Instead of abandoning LLM-based chatbot pilots over hallucination risks, we design safe, evidence-driven LM-Arena-style experiments where LLMs, SLMs, and predefined models compete under controlled, in-silico conditions using simulated patient personas.
These experiments build trust, generate publishable data, and position teams as credible innovators.

Measured fit. Validated from the relevant angles.
Our PMF model combines both classic and venture metrics to ensure depth and accountability:

• User validation: Sean Ellis Test (>40 % “very disappointed” threshold) and Olsen’s PMF Pyramid.

• Business traction: CAC, CLV, conversion performance and more.

• Impact assurance: proven value for Pharma, patients, and investors alike.

PMF and GTM - the Ying and Yang of Success.
PMF validates why the product matters; GTM scales how it wins.
Both are driven by our Zero-Click Mindset - simplifying complexity until differentiation becomes obvious, measurable, and a competitive edge.

Clarity first - not campaigns.
Most Go-to-Market failures aren’t marketing issues - they’re positioning gaps. We help partners articulate who their product is for and why it matters, turning complex technology and science into clear, credible value that resonates.

The Zero-Click Mindset is what sets us apart.
It connects deep experience in Pharma and Tech with the discipline to simplify until the advantage becomes obvious and defensible. True differentiation starts here - not in creative assets, but in strategic focus.

PMF and GTM run in parallel. Case STudy Ceel.AI
PMF validates why the product matters; GTM scales how it wins. At Ceel.AI, we achieved Product-Market-Fit within 14 days - establishing a defensible moat through Pharma personas, topic frameworks (e.g., dosage, side effects, patient needs), and a dynamic question catalog. This positioned Ceel.AI as the first real-time engagement platform giving Pharma leaders instant visibility into audience interests, sentiment and sources - fully pre-configured, almost zero-click.

What took weeks now happens in minutes.

With clarity secured, pricing and packaging aligned naturally around a stronger, compliant, and distinctive offer.

What looks effortless is the result of radical clarity - and years of learning what not to complicate.

Our support is truly end-to-end - starting long before the first sales call.
Effective sales enablement is impossible without an excellent Product-Market-Fit and clear, easily understood differentiation.

A premature Executive-level introduction is a "one-way door"; if the product doesn't fit the challenge or is too complex, that door, and others, will close permanently. The pharma world is small, and executives exchange feedback regularly. We make sure those first impressions create long-term traction, not short-term exposure.

Clarity before execution.
We begin by understanding and optimizing your PMF and GTM, identifying the levers where our proprietary Impact-First and Zero-Click Mindset approaches create measurable advantage.

Only then do we execute hands-on enablement - through workshops, playbooks, and executive keynotes that align both internal teams and external customers.
A good product becomes an excellent one - and a true bestseller - only when both audiences are convinced.

From foundation to follow-through.
Once this foundation is set, we address all downstream topics: pricing, packaging, marketing, and customer support. Our track record covers this full end-to-end process. This is our key differentiator: real experience, real results.

The public track record of our founder, Dr. Patrick Markt-Niederreiter, can be reviewed under Media Releases, with additional case studies available on request.

In short: we don’t sell playbooks - we help teams write the ones that work.

We price for value, not usage.
Our first principle is simple: impact before income.
We help clients create and communicate clear, convincing value - so their customers instantly see why it matters. Every successful case we’ve led follows the same pattern: focus on solving the biggest customer challenge, using only the functions that truly move the needle.

Example — Ceel.AI.
Together we’ve designed a real-time customer insight solution powered by LLM-based persona simulations.
Pharma leaders can now discover within minutes - not weeks - what patients, physicians, or payers want to know about a specific therapy or disease.
It’s fully preconfigured yet adaptable, scalable across markets, and light on complexity.
Here, value means “gaining customer understanding in near real time” - something previously impossible in Pharma.
A volume-based model would have sold each module (persona, disease, question set) separately - maximizing revenue but killing adoption. Value over Volume did the opposite: it multiplied impact and credibility.

Why this matters.
Traditional pricing models (license, subscription, pay-as-you-go) assume predictable usage.
In Pharma and HealthTech, that’s rarely the case. Early adoption is uncertain: user numbers, usage frequency, and scalability evolve over time.
Pricing for impact removes that friction. It ensures clients pay for solving their core problem, not for each click, seat, or data call.
Scalability becomes a shared benefit, not a hidden cost.

In short:we design pricing that rewards outcomes, not activity - because real impact scales itself.